| Literature DB >> 29403718 |
Min Ye1, Wen-Zhi Yang1, Ke-Di Liu1, Xue Qiao1, Bei-Jia Li1, Jun Cheng1, Jie Feng1, De-An Guo1, Yu-Ying Zhao1.
Abstract
Millettia nitida var. hirsutissima is a Chinese herbal medicine used for the treatment of gynecological diseases. An HPLC/DAD/ESI-MS n method was established for the rapid separation and characterization of bioactive flavonoids in M. nitida var. hirsutissima. A total of 32 flavonoids were detected, of which 14 compounds were unambiguously characterized by comparing their retention time, UV, and MS spectra with those of the reference standards, and the others were tentatively identified based on their tandem mass spectrometry fragmentation data obtained in the negative ionization mode on line. Nineteen of these compounds characterized were reported from this plant for the first time.Entities:
Keywords: Flavonoids; HPLC/DAD/ESI-MSn; Mass spectrometry; Millettia nitida var. hirsutissima
Year: 2011 PMID: 29403718 PMCID: PMC5760832 DOI: 10.1016/j.jpha.2011.09.009
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Figure 1HPLC and ESI-MS chromatograms of Millettia nitida var. hirsutissima. (A) HPLC chromatogram at 280 nm; (B) ESI-MS chromatogram in the negative mode.
Compounds identified from Millettia nitida var. hirsutissima.
| 1 | 5.29 | 212 | 289 | 289→245(100), 205(30), 227(1), 203(1), 179(10), 161(1), 137(1) | (+)-Catechin |
| 2 | 8.51 | 463 | 463→301(100), 343(1), 313(1), 255(1) | Quercetin- | |
| 301→257(100), 259(70), 283(35), 273(25), 271(5), 151(5) | |||||
| 3 | 10.29 | 463 | 463→301(100), 343(1), 255(1), 191(1) | Quercetin- | |
| 301→257(100), 259(70), 283(35), 273(25), 271(5), 151(15), 135(5) | |||||
| 4 | 12.54 | 230, 278 | 287 | 287→269(100), 259(15), 225(1)163(15), 109(1), 135(1) | 3, 7, 3′, 4″-Tetrahydroxyflavanone |
| 269→225(100), 241(20), 201(1), 163(20) | |||||
| 5 | 12.57 | 431 | 431→311(100), 283(4), 341(4) | Isovitexin | |
| 6 | 14.36 | 230, 268 | 445 | 445→283(100) | Calycosin- |
| 283→268(100), 255(1), 239(1), 211(1) | |||||
| 7 | 15.16 | 577 | 577→269(100), 503(3) | Sphaerobioside | |
| 269→269(100), 240(20) | |||||
| 8 | 15.45 | 226, 268 | 303 | 303→285(100), 193(1) | Dihydroquercetin |
| 285→241(100), 175(40), 217(20), 213(1), 243(15), 177(1) | |||||
| 9 | 16.06 | 431 | 431→268(100), 311(10), 341(1), 371, (1), 223(1) | Genistin | |
| 268→267(100), 240(60), 224(40), 226(20), 211(20) | |||||
| 10 | 16.79 | 299 | 299→284(100), 299(1) | Isomer of 3′- | |
| 284→284(100), 135(10), 256(20)241(10), 212(20), 228(20), 200(20), 148(20), 136(5) | |||||
| 11 | 17.28 | 579 | 579→271(100), 269(10), 313(5), 417(10), 519(1), 533(1) | Trihydroxyflavanone- | |
| 271→151(100), 177(80) | |||||
| 12 | 17.87 | 461 | 461→446(100), 298(80), 371(1), 341(50), 283(20), 269(1), 164(1) | Gliricidin- | |
| 446→283(100), 255(15), 211(1) | |||||
| 13 | 18.93 | 299 | 299→284(100), 299(50), 271(15), 256(10), 212(1), 175(1) | Gliricidin | |
| 284→256(100), 227(20), 212(5), 200(5) | |||||
| 14 | 20.72 | 230, 278 | 271 | 271→135(100), 153(60), 253(30), 243(1), 183(1), 91(1) | 7, 3′, 4′-Trihydroxyflavanone |
| 15 | 21.16 | 226, 262 | 447 | 447→285(100) | Tetrahydroxyisoflavone- |
| 285→285(100), 257(20), 240(5), 229(20), 212(10), 199(17), 176(15) | |||||
| 16 | 23.61 | 561 | 561→267(100), 545(1), 532(1), 252(1)267→252(100) | Formononetin-7- | |
| 17 | 26.18 | 262 | 267 | 267→252(100), 267(30) | Formononetin |
| 252→251(100), 223(60), 208(40), 195(10), 168(1), 132(10) | |||||
| 18 | 26.9 | 226, 278 | 269 | 269→269(100), 225(40), 241(30), 251(10), 213(1), 197(10), 133(20) | Genistein |
| 19 | 27.93 | 255 | 255→255(1), 153(80), 135(100), 119(20), 91(5) | Liquiritigenin | |
| 20 | 29.24 | 230, 288 | 283 | 283→268(100), 283(10), 240(5) | Isomer of calycosin |
| 268→240(100), 267(1)224(20), 211(30), 196(10), 184(5), 120(5), 135(5) | |||||
| 21 | 30.23 | 285 | 285→135(100), 153(80), 149(75), 270(60), 285(20), 256(5), 91(50) | 7-Methoxy-3′, 4′ –dihydroxyl flavanone | |
| 22 | 31.57 | 230, 290 | 283 | 283→268(100), 283(1), 224(1) | Calycosin |
| 268→240(100), 268(40), 224(30), 211(40), 195(15), 184(20), 135(1), 120(5), 148(1) | |||||
| 23 | 34.14 | 577 | 577→283(100), 268(10) | Lanceolarin | |
| 283→268(100), 283(10) | |||||
| 268→267(100), 240(15), 223(10) | |||||
| 24 | 38.52 | 380 | 271 | 271→253(25), 228(1), 135(100), 153(80), 109(1), 91(1) | 3, 4, 2′, 4′-Tetrahydroxychalcone |
| 153→135(100), 153(40) | |||||
| 25 | 38.91 | 260 | 283 | 283→268(100), 283(20) | Isomer of calycosin |
| 268→267(100), 240(60), 224(40), 226(20), 211(20) | |||||
| 26 | 42.15 | 230, 264 | 299 | 299→284(100), 299(20), 271(10), 256(1) | 3′- |
| 284→284(100), 267(10)256(80), 240(20), 227(30), 212(1), 148(5) | |||||
| 27 | 49.31 | 370 | 255 | 255→254(1), 213(1), 153(60), 135(100), 119(40), 91(5) | Isoliquiritigenin |
| 28 | 51.13 | 242 | 267 | 267→252(100), 267(20) | Isomer of formononetin |
| 252→252(100), 223(90), 208(40), 195(1), 132(10) | |||||
| 29 | 51.66 | 230, 282 | 297 | 297→282(100), 267(10), 253(1) 282→267(100), 281(1), 239(20) | 8- |
| 267→239(100), 223(20), 267(5), 211(1) | |||||
| 30 | 51.73 | 226, 284 | 271 | 271→109(100), 256(70), 253(80), 227(40), 135(60) | 7, 2′-Dihydroxy-4-methoxyl isoflavan |
| 31 | 51.82 | 380 | 285 | 285→135(100), 270(95), 153(60), 149(60) 243(20), 214(1), 201(1) | 3, 2′, 4′, -Trihydroxy-4-methoxychalcone |
| 32 | 60.37 | 262 | 283 | 283→268(100), 283(10) | Maackiain |
| 268→267(100), 240(60), 224(40), 212(5), 196(1), 164(1), 109(1) |
The compound was unambiguously identified by comparing with reference standards.
The compound had been reported from this plant. The reference was labeled.
Figure 2Selected chemical structures of identified compounds (compounds 1, 4, 5, 7, 9, 13, 14, 16, 17, 18, 19, 21, 22, 23, 24, 26, 27, 29, 30, 31 and 32).
Figure 3The MS3 spectra of calycosin, gliricidin and formononetin.
Figure 4The MS3 spectra of compound 14, 19 and 21.
Figure 5The MS3 spectra of 24, 27 and 31.
Scheme 1A proposed fragmentation pathway of maackiain.